A Systematic Review of the Cost-Effectiveness of Biologics for the Treatment of Inflammatory Bowel Diseases

por Huoponen, Saara, Blom, Marja
Publicado 2015

Health service use and costs associated with fluoroquinolone‐related tendon injuries

por Kuula, Laura S. M., Backman, Janne T., Blom, Marja L.
Publicado 2021

Healthcare costs and mortality associated with serious fluoroquinolone‐related adverse reactions

por Kuula, Laura S.M., Backman, Janne T., Blom, Marja L.
Publicado 2022

Fluoroquinolone-related adverse events resulting in health service use and costs: A systematic review

por Kuula, Laura S. M., Viljemaa, Kati M., Backman, Janne T., Blom, Marja
Publicado 2019

Automated dose dispensing service for primary healthcare patients: a systematic review

por Sinnemäki, Juha, Sihvo, Sinikka, Isojärvi, Jaana, Blom, Marja, Airaksinen, Marja, Mäntylä, Antti
Publicado 2013

The Cost-Effectiveness of Biologics for the Treatment of Rheumatoid Arthritis: A Systematic Review

por Joensuu, Jaana T., Huoponen, Saara, Aaltonen, Kalle J., Konttinen, Yrjö T., Nordström, Dan, Blom, Marja
Publicado 2015

Systematic Review and Meta-Analysis of the Efficacy and Safety of Existing TNF Blocking Agents in Treatment of Rheumatoid Arthritis

por Aaltonen, Kalle J., Virkki, Liisa M., Malmivaara, Antti, Konttinen, Yrjö T., Nordström, Dan C., Blom, Marja
Publicado 2012

Health-related quality of life and costs of switching originator infliximab to biosimilar one in treatment of inflammatory bowel disease

por Huoponen, Saara, Eberl, Anja, Räsänen, Pirjo, Roine, Risto P., Sipponen, Taina, Arkkila, Perttu, Blom, Marja
Publicado 2020

Health-related quality of life in patients waiting for major joint replacement. A comparison between patients and population controls

por Hirvonen, Johanna, Blom, Marja, Tuominen, Ulla, Seitsalo, Seppo, Lehto, Matti, Paavolainen, Pekka, Hietaniemi, Kalevi, Rissanen, Pekka, Sintonen, Harri
Publicado 2006

The effect of co-morbidities on health-related quality of life in patients placed on the waiting list for total joint replacement

por Tuominen, Ulla, Blom, Marja, Hirvonen, Johanna, Seitsalo, Seppo, Lehto, Matti, Paavolainen, Pekka, Hietanieni, Kalevi, Rissanen, Pekka, Sintonen, Harri
Publicado 2007

A Systematic Review of Cost-Sharing Strategies Used within Publicly-Funded Drug Plans in Member Countries of the Organisation for Economic Co-Operation and Development

por Barnieh, Lianne, Clement, Fiona, Harris, Anthony, Blom, Marja, Donaldson, Cam, Klarenbach, Scott, Husereau, Don, Lorenzetti, Diane, Manns, Braden
Publicado 2014

Cost-utility of routine cataract surgery

por Räsänen, Pirjo, Krootila, Kari, Sintonen, Harri, Leivo, Tiina, Koivisto, Anna-Maija, Ryynänen, Olli-Pekka, Blom, Marja, Roine, Risto P
Publicado 2006

Cost-effectiveness of abatacept, tocilizumab and TNF-inhibitors compared with rituximab as second-line biologic drug in rheumatoid arthritis

por Huoponen, Saara, Aaltonen, Kalle J., Viikinkoski, Jaana, Rutanen, Jarno, Relas, Heikki, Taimen, Kirsi, Puolakka, Kari, Nordström, Dan, Blom, Marja
Publicado 2019